Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment

The past two decades have brought many important advances in our understanding of the hereditary susceptibility to cancer. Numerous studies have provided convincing evidence that identification of germline mutations associated with hereditary cancer syndromes can lead to reductions in morbidity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Vysotskaia, Valentina S., Hogan, Gregory J., Gould, Genevieve M., Wang, Xin, Robertson, Alex D., Haas, Kevin R., Theilmann, Mark R., Spurka, Lindsay, Grauman, Peter V., Lai, Henry H., Jeon, Diana, Haliburton, Genevieve, Leggett, Matt, Chu, Clement S., Iori, Kevin, Maguire, Jared R., Ready, Kaylene, Evans, Eric A., Kang, Hyunseok P., Haque, Imran S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2017
Materias:
Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326550/
https://www.ncbi.nlm.nih.gov/pubmed/28243543
http://dx.doi.org/10.7717/peerj.3046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326550/
https://www.ncbi.nlm.nih.gov/pubmed/28243543
http://dx.doi.org/10.7717/peerj.3046

Ejemplares similares